ARTICLE | Clinical News
CVD 908-htrA oral typhoid vaccine: Phase II
January 11, 1999 8:00 AM UTC
Results from an 80-volunteer cross-over trial compared dose levels of 5 x 107 and 4.5 x 108 colony forming units to placebo. Cells secreting IgA antibodies against S. typhi lipopolysaccharide (LPS) a...